AI English summary of an SEC filing — figures as filed
Clorox CLXClorox said its board appointed Fabian Garcia as CEO and a director on October 28, 2026, effective January 5, 2027. Linda Rendle will step down as CEO, chair and director on that date and serve as a senior advisor through April 2, 2027.
Key points
AI summaryClorox said its board appointed Fabian Garcia as CEO and a director on October 28, 2026, effective January 5, 2027. Linda Rendle will step down as CEO, chair and director on that date and serve as a senior advisor through April 2, 2027.
The company said Matthew J. Shattock, currently lead independent director, will serve as independent chair from the effective date. For the role, he will receive an independent chair retainer of $225,000 on top of the annual director retainer and annual deferred stock unit grant.
Clorox said Garcia's annual base salary will be $100,000, and his annual short-term incentive target bonus will be $2,000,000, settled in stock and prorated for fiscal 2027. The company said his long-term incentive target value will be $4,550,000, and from September 2027 his annual long-term incentive target value will be $9,100,000.
Clorox said Garcia will receive a one-time sign-on restricted stock unit award with a target value of $11,000,000 to offset equity awards he forfeits at his prior employer. The award will vest ratably over 3 years, subject to continued employment. The company said Rendle's base salary of $1,350,000 will remain in effect during her advisory period, and she will not receive additional long-term or equity awards during that period.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Fabian Garcia Named CEO, Effective January 5, 2027
Clorox said its board appointed Fabian Garcia as CEO and a director on October 28, 2026, effective January 5, 2027. Linda Rendle will step down as CEO, chair and director on that date and serve as a senior advisor through April 2, 2027.
Source · Based on the filing body and exhibits
Matthew J. Shattock to Serve as Independent Chair
The company said Matthew J. Shattock, currently lead independent director, will serve as independent chair from the effective date. For the role, he will receive an independent chair retainer of $225,000 on top of the annual director retainer and annual deferred stock unit grant.
Source · Based on the filing body and exhibits
Garcia Offer Letter: Salary and Incentive Targets
Clorox said Garcia's annual base salary will be $100,000, and his annual short-term incentive target bonus will be $2,000,000, settled in stock and prorated for fiscal 2027. The company said his long-term incentive target value will be $4,550,000, and from September 2027 his annual long-term incentive target value will be $9,100,000.
Source · Based on the filing body and exhibits
Garcia Sign-On RSUs and Rendle Advisory Terms
Clorox said Garcia will receive a one-time sign-on restricted stock unit award with a target value of $11,000,000 to offset equity awards he forfeits at his prior employer. The award will vest ratably over 3 years, subject to continued employment. The company said Rendle's base salary of $1,350,000 will remain in effect during her advisory period, and she will not receive additional long-term or equity awards during that period.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…